CBS and early-onset autosomal dominant Alzheimer disease: It was noted, however, that intraventricular administration of homocysteine, a risk factor for the development of Alzheimer's disease, reduces the level of CBS expression in the rat hippocampus with simultaneous impairment of memory and learning.